OPRM1 and respiratory depression: β-Arrestin Activity: Unlike traditional opioids, mitragynine does not recruit β-arrestin 2 at the mu-opioid receptor, which is significant because β-arrestin 2 recruitment is linked to several adverse effects of opioids, including respiratory depression, constipation, and tolerance [15].